EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Chemoreflex function in pulmonary diseases – A review

Kajal Kamra iD, Zhiqiu Xia, Irving H Zucker iD, Harold Schultz iD, Han-Jun Wang iD

The Journal of Physiology · 2025-08 · 603 (16) · 4461-4482

DOI: 10.1113/jp286655 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, published online on 2025-07-31. Written by Kajal Kamra and 4 co-authors. Institution: Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA. Major MEDLINE topics: Chemoreceptor Cells, Lung Diseases, Reflex. Cited 22 times so far (Crossref); 220 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHLBI NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The chemoreflex is a vital protective reflex that is crucial in restoring normal blood gas and pH levels. The carotid bodies are peripheral chemoreceptors activated by hypoxia (primarily), hypercapnia, acidaemia, temperature, lactate and potassium fluctuations. They are crucial for maintaining physiological conditions based on underlying causes and blood gas abnormalities. Central chemoreceptors in the brain stem are responsive to hypercapnia and contribute to blood gas regulation. Chemoreceptors regained attention during the SARS‐CoV‐2 (COVID‐19) pandemic, potentially contributing to disease severity. In conditions like chronic intermittent hypoxia, chemoreflex sensitization may lead to respiratory disorders, impacting quality of life. There has been substantial research/evidence linking chemoreflex dysfunction to cardiovascular illnesses such as heart failure and hypertension. However, little emphasis has been placed on the role of the chemoreflex in mediating cardiopulmonary dysfunction during and after pulmonary disorders such as acute lung injury. The current review summarizes recent advances in the study of chemoreflex malfunction and the underlying mechanisms in acute and chronic lung diseases such as COVID‐19 infection, chronic obstructive pulmonary disease, asthma, obstructive sleep apnoea and acute lung injury. image

Subjects

MeSH terms (MEDLINE)

Chemoreceptor CellsLung DiseasesReflexHumansCOVID-19AnimalsSARS-CoV-2Carotid Body

Author keywords

COPDCOVID‐19acute lung injurycarotid bodieschemoreflexobstructive sleep apnoea

Authors and institutions

  • Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Anesthesiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

ORCID profiles: Kajal Kamra, Irving H Zucker, Harold Schultz, Han-Jun Wang

Funding

  • NHLBI NIH HHS

Cite

APA

Kamra, K., Xia, Z., Zucker, I. H., Schultz, H., & Wang, H. J. (2025). Chemoreflex function in pulmonary diseases – A review. The Journal of Physiology, 603(16), 4461-4482. https://doi.org/10.1113/jp286655

Vancouver

Kamra K, Xia Z, Zucker IH, Schultz H, Wang HJ. Chemoreflex function in pulmonary diseases – A review. The Journal of Physiology. 2025;603(16):4461-4482. doi:10.1113/jp286655

BibTeX
@article{Kamra2025,
  author = {Kamra, Kajal and Xia, Zhiqiu and Zucker, Irving H and Schultz, Harold and Wang, Han-Jun},
  title = {Chemoreflex function in pulmonary diseases – A review},
  journal = {The Journal of Physiology},
  year = {2025},
  volume = {603},
  number = {16},
  pages = {4461--4482},
  doi = {10.1113/jp286655}
}
Start for free →